Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
A.29EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
A.29EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.147EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.147EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
P.1.6 (Gamma)EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
P.1.6 (Gamma)EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
P.1.5 (Gamma)EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
P.1.5 (Gamma)EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
P.1.4 (Gamma)EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
P.1.4 (Gamma)EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.420EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.420EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
XBB.2.12EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
XBB.2.12EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BF.39.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
BF.39.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
EK.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
EK.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.233EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.233EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.177.74EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.177.74EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BA.2.25EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
BA.2.25EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.1.237EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.1.237EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
XBNEHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
XBNEHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
XBJ.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
XBJ.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.356EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.356EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BQ.1.33EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
BQ.1.33EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
XBB.1.29EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
XBB.1.29EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BA.5.1.28EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
BA.5.1.28EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
CL.1.3EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
CL.1.3EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BM.1.1.4EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
BM.1.1.4EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
XBMEHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
XBMEHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BF.34EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
BF.34EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
CB.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
CB.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BR.3EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
BR.3EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used